These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 3953353)

  • 41. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amiodarone-induced torsades de pointes.
    Brown MA; Smith WM; Lubbe WF; Norris RM
    Eur Heart J; 1986 Mar; 7(3):234-9. PubMed ID: 3709557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias.
    Kerin NZ; Blevins RD; Frumin H; Faitel K; Rubenfire M
    Am J Cardiol; 1985 Jan; 55(1):89-91. PubMed ID: 3966403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
    Hamer AW; Finerman WB; Peter T; Mandel WJ
    Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease.
    Russo AM; Beauregard LM; Waxman HL
    Am J Cardiol; 1993 Dec; 72(18):1395-9. PubMed ID: 8256733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias.
    Wheeler PJ; Puritz R; Ingram DV; Chamberlain DA
    Postgrad Med J; 1979 Jan; 55(639):1-9. PubMed ID: 432163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up.
    Peter T; Hamer A; Mandel WJ; Weiss D
    Am Heart J; 1983 Oct; 106(4 Pt 2):943-50. PubMed ID: 6613841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
    Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term tolerance of amiodarone treatment for cardiac arrhythmias.
    Smith WM; Lubbe WF; Whitlock RM; Mercer J; Rutherford JD; Roche AH
    Am J Cardiol; 1986 Jun; 57(15):1288-93. PubMed ID: 3717027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Newer antiarrhythmic drugs in children.
    Moak JP; Smith RT; Garson A
    Am Heart J; 1987 Jan; 113(1):179-85. PubMed ID: 3099560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Experience with intravenous amiodarone in hyperkinetic supraventricular arrhythmias].
    Ricevuti A; Bianchi C; Bonifazi C; Coppetti S; Ferrari O; Rinaldo R; Rizzi M; Tavecchi L; Zampaglione G; Ziletti G; Distante S
    G Ital Cardiol; 1981; 11(6):812-9. PubMed ID: 7319187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation.
    Nalos PC; Ismail Y; Pappas JM; Nyitray W; DonMichael TA
    Am Heart J; 1991 Dec; 122(6):1629-32. PubMed ID: 1957758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amiodarone in the treatment of patients with refractory symptomatic ventricular and supraventricular arrhythmias. A long-term follow-up study.
    Lloyd EA; Mabin TA
    S Afr Med J; 1983 May; 63(20):759-63. PubMed ID: 6342169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of amiodarone on refractory ventricular fibrillation in acute myocardial infarction: experimental study.
    Anastasiou-Nana MI; Nanas JN; Nanas SN; Rapti A; Poyadjis A; Stathaki S; Moulopoulos SD
    J Am Coll Cardiol; 1994 Jan; 23(1):253-8. PubMed ID: 8277089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. QT prolongation and the antiarrhythmic efficacy of amiodarone.
    Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
    J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy.
    Singh BN
    Clin Cardiol; 1997 Jul; 20(7):608-18. PubMed ID: 9220176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
    Haffajee CI; Love JC; Canada AT; Lesko LJ; Asdourian G; Alpert JS
    Circulation; 1983 Jun; 67(6):1347-55. PubMed ID: 6851030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.